On Invalid Date, Immunocore Holdings (NASDAQ: IMCR) reported Q4 2023 earnings per share (EPS) of -$0.39, up 44% year over year. Total Immunocore Holdings earnings for the quarter were -$19.20 million. In the same quarter last year, Immunocore Holdings's earnings per share (EPS) was -$0.70.
As of Q2 2024, Immunocore Holdings's earnings has grown year over year. Immunocore Holdings's earnings in the past year totalled -$55.29 million.
What is IMCR's earnings date?
Immunocore Holdings's earnings date is Invalid Date. Add IMCR to your watchlist to be reminded of IMCR's next earnings announcement.
What was IMCR's revenue last quarter?
On Invalid Date, Immunocore Holdings (NASDAQ: IMCR) reported Q4 2023 revenue of $69.69 million up 27.24% year over year. In the same quarter last year, Immunocore Holdings's revenue was $54.77 million.
What was IMCR's revenue growth in the past year?
As of Q2 2024, Immunocore Holdings's revenue has grown 43.05% year over year. This is 101.58 percentage points lower than the US Biotechnology industry revenue growth rate of 144.63%. Immunocore Holdings's revenue in the past year totalled $249.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.